Researchers from Purdue University's Discovery Park and the Korean Institute of Science and Technology (KIST) are scheduled to meet on September 6 to discuss the development of molecular imaging and nanotechnology tools to simultaneously diagnose and treat cancer and chronic and infectious diseases
The $4.5 million research initiative also will focus on next-generation tools for theragnosis, which combines simultaneous diagnostics and therapeutics.
In 2006, the South Korean Ministry of Education, Science and Technology selected the KIST/Purdue project from 20 international research proposals submitted to examine how to learn more about the molecular makeup of diseases.
